亚游集团官网

EUREKA Therapeutics,Inc.(亚游集团官网 生物技术公司)创建于2006年,总部亚游集团官网位于生物技术产业最活跃的美国加州旧金山湾区,亚游集团官网 (北京)生物技术有限公司为其全资子公司,现坐落于北京清华科技园。

亚游集团官网始终专注于针对癌症的新一代治疗性单抗药物的开发,公司拥有多项国际专利和自主知识产权的核心技术,如大容量的全人源噬菌体抗体库、抗体ADCC增强技术等。在抗体药物研发的前期阶段均积攒了丰富的经验,获得多家全球知名企业的高度认可,并建立了长期合作伙伴关系。

  • Eureka and BI Announce a Collaboration

    Eureka Therapeutics Inc. and Boehringer Ingelheim Announce a Collaboration to Identify Next Generation Antibodies for Cancer Treatment

  • Raises $21 Million in Series C Financing

    亚游集团官网Eureka Therapeutics, Inc. announced today that the Company has secured $21 million in a Series C Financing. The new funding will be used to expand the

  • Press Releases

    Eureka Therapeutics and Memorial Sloan-Kettering Cancer Center announced that they have entered into a license agreement with Novartis for the develop

View All
百家乐网址AG真人AG真人yp街机AGin games客户端